Skip to content

SARS-CoV-2

Optimer™ reagents bind to RBD of UK COVID-19 variant

We demonstrate that Optimer binders show equivalent binding to both the WT and new COVID-19 variant for continued reliable results in research, diagnostics and therapeutics. Newly emerging, fast-spreading variants of…

Integumen signs MTA with Aptamer Group Ltd

09/07/2020 Collaboration to use aptamers in a device to detect SARS-CoV-2 in wastewater Aptamer Group, developers of Aptamer reagents, is pleased to announce that it has signed…